Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review

  • ID: 1322529
  • SWOT Analysis
  • 65 pages
  • GlobalData
  • Amgen Inc.
1 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Celgene Corp
  • Exelixis Inc
  • Genentech Inc
  • NewLink Genetics Corp
  • Novartis AG
  • MORE
Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncology/hematology, inflammation, bone health, neuroscience and nephrology. The company develops products by using advanced human genetics to unravel the difficulties of disease and understand the fundamentals of human biology. Amgen sells its products primarily to pharmaceutical wholesale distributors in the US. It also markets certain products directly to consumers by television advertising, direct-to-consumer print and multi-channel marketing. Amgen is headquartered in Thousand Oaks, California, the US.

Amgen Inc Key Recent Developments

Feb 01, 2018: Amgen Reports Fourth Quarter And Full Year 2017 Financial Results
Jan 23, 2018: Frontiers in Physiology Publishes Research Showing Pro-Arrhythmia Risk Predictivity of Adult Human Primary Ventricular Tissue-Based Model
Jan 09, 2018: BC Platforms to Provide Big Data Driven Research Solutions to Amgen in Cardiovascular Diseases and Oncology
Dec 12, 2017: Amgen Announces 15 Percent Increase In 2018 First Quarter Dividend
Dec 11, 2017: Amgen Foundation Pledges Up To $500,000 In Relief To Victims Of The Southern California Wildfires

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Celgene Corp
  • Exelixis Inc
  • Genentech Inc
  • NewLink Genetics Corp
  • Novartis AG
  • MORE
Section 1 - About the Company
  • Amgen Inc - Key Facts
  • Amgen Inc - Key Employees
  • Amgen Inc - Key Employee Biographies
  • Amgen Inc - Major Products and Services
  • Amgen Inc - History
  • Amgen Inc - Company Statement
  • Amgen Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Amgen Inc - Business Description
  • Business Segment: Human Therapeutics
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Other Revenues
  • Performance
  • Business Segment: Other Segment
  • Overview
  • Geographical Segment: Rest of the world (ROW)
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • Amgen Inc - Corporate Strategy
  • Amgen Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Amgen Inc - Strengths
  • Amgen Inc - Weaknesses
  • Amgen Inc - Opportunities
  • Amgen Inc - Threats
  • Amgen Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Amgen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Amgen Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Feb 01, 2018: Amgen Reports Fourth Quarter And Full Year 2017 Financial Results
  • Jan 23, 2018: Frontiers in Physiology Publishes Research Showing Pro-Arrhythmia Risk Predictivity of Adult Human Primary Ventricular Tissue-Based Model
  • Jan 09, 2018: BC Platforms to Provide Big Data Driven Research Solutions to Amgen in Cardiovascular Diseases and Oncology
  • Dec 12, 2017: Amgen Announces 15 Percent Increase In 2018 First Quarter Dividend
  • Dec 11, 2017: Amgen Foundation Pledges Up To $500,000 In Relief To Victims Of The Southern California Wildfires
  • Dec 07, 2017: New Data To Be Presented At ASH 2017 Underscore Amgen's Commitment To Improving Lives And Changing Outcomes For Patients With Difficult-To-Treat Blood Cancers
  • Oct 25, 2017: Amgen Reports Third Quarter 2017 Financial Results
  • Oct 24, 2017: Amgen Announces Appointment Of Wanda M. Austin To Board Of Directors
  • Oct 06, 2017: Amgen And LabCentral Open Nomination Process For Lab Residency
  • Sep 25, 2017: Amgen Provides Update On Hurricane Maria
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Amgen Inc, Key Facts
  • Amgen Inc, Key Employees
  • Amgen Inc, Key Employee Biographies
  • Amgen Inc, Major Products and Services
  • Amgen Inc, History
  • Amgen Inc, Other Locations
  • Amgen Inc, Subsidiaries
  • Amgen Inc, Joint Venture
  • Amgen Inc, Key Competitors
  • Amgen Inc, Annual Ratios
  • Amgen Inc, Annual Ratios
  • Amgen Inc, Annual Ratios
  • Amgen Inc, Interim Ratios
  • Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Amgen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Amgen Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Amgen Inc, Performance Chart (2013 - 2017)
  • Amgen Inc, Ratio Charts
  • Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Amgen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Teva Pharmaceutical Industries Ltd
  • SynZyme Technologies LLC
  • Sangamo Therapeutics Inc
  • Roxane Laboratories Inc
  • Quanta BioDesign Ltd
  • Pfenex Inc
  • Novartis AG
  • Nordion (Canada) Inc
  • NewLink Genetics Corp
  • Millennium Pharmaceuticals Inc
  • Ligand Pharmaceuticals Inc
  • Innovation Pharmaceuticals Inc
  • GlaxoSmithKline Plc
  • Genentech Inc
  • Fresenius Medical Care AG & Co KGaA
  • F. Hoffmann-La Roche Ltd
  • Exelixis Inc
  • Eli Lilly and Co
  • Celgene Corp
  • Bristol-Myers Squibb Co
  • AbbVie Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll